# Carbapenem Antibiotic Therapy for VIM Carbapenemase-Producing Enterobacteriaceae Infections

> **NCT06185153** · — · UNKNOWN · sponsor: **University Hospital, Strasbourg, France** · enrollment: 70 (estimated)

## Conditions studied

- Carbapenemase-Producing Enterobacteriaceae

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06185153
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-21
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2023-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06185153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06185153, "Carbapenem Antibiotic Therapy for VIM Carbapenemase-Producing Enterobacteriaceae Infections". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06185153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*